Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
Physicians should be vigilant about the dual impact of GLP-1 drugs on contraceptive failure and unexpected fertility enhancements, prompting a reassessment of patient guidance and contraceptive choices in clinical practice.
Endocrinology, Diabetes, Metabolism April 3rd 2024
MDLinx
Physicians should advise patients on the judicious use of olive oil, emphasizing its role in a balanced diet and cautioning against excessive consumption that could lead to gastrointestinal and metabolic adverse effects.
Family Medicine/General Practice March 20th 2024
Pharmacy Learning Network
In the midst of stabilizing adolescent drug use rates, the surge in overdose deaths calls for a nuanced understanding and approach to SUDs among young populations.
Family Medicine/General Practice March 19th 2024
Medical News Today (MNT)
This study reveals that prebiotic fiber supplementation can significantly improve cognitive functions in older adults, offering a promising direction for non-pharmacological interventions in age-related cognitive decline.
GLP-1 agonists are increasingly recognized for their dual benefits in type 2 diabetes management and cardiovascular risk reduction, offering a multifaceted approach to patient care in an expanding global market.
Cardiology March 13th 2024
Cleveland Clinic Journal of Medicine
Metformin is emerging as a viable option for weight management in obese patients without diabetes, showing sustained weight loss effects and potential benefits in populations with prediabetes or undergoing antipsychotic treatment.
Endocrinology, Diabetes, Metabolism March 13th 2024